UW Program for Advanced Cell Therapy

The UW Program for Advanced Cell Therapy is a research institution located in Madison, Wisconsin. They employ 10 individuals and generate approximately $2.5 million in annual revenue. The UW Program for Advanced Cell Therapy supports researchers, clinicians, and external partners in developing advanced cell and gene therapies. Their services encompass FDA-compliant production of various cell types, advanced cell manufacturing, and cell enrichment. They assist in developing Standard Operating Procedures, Batch Production Records, and IND filings, including writing and reviewing CMC reports. The program specializes in vein-to-vein (POCV2V) cell therapy manufacture, offering clinical deployment capabilities. They actively participate in Phase I clinical trials and welcome collaborations for multi-center trials. Additionally, they partner with biotechnology and medical device companies to integrate semi-automated and fully automated devices into GMP workflows. Their website can be accessed at pact.wisc.edu.